2nd Int'l Congress on Clinical Trials in Oncology & Hemato-Oncology 2018

ICTO2018 follows the success of ICTO2017 which took place in March 2017 in London and will again bring together world renowned speakers in the field of Clinical Trials in Oncology and Hemato-Oncology.

It gives us great pleasure to invite you to attend The 2nd International Congress on Clinical Trials in Oncology and Hemato-Oncology (ICTO2018) scheduled to take place in Berlin, Germany from 19-20 February 2018.

ICTO2018 follows the success of the 1st inaugural Congress which took place March 2017 in London and will again bring together world renowned speakers in the field of Clinical Trials in Oncology and Hemato-Oncology.  The Congress will welcome oncology professionals, treatment experts, CRO’s, industry leaders and other experts to the majestic city of Berlin.

ICTO2018 will provide an outstanding scientific, educational and networking experience.

The congress will focus on areas including:

- Design of clinical trials in the new era - Personalized cancer medicine

- Immuno-oncology

- Monitoring of Trials and Statistics

- Regulations – Survival based Medicine

- Phase 4 Trials

- Expanded access trials

- Ethics and Patients’ Rights

- Healthcare economy

Our goal is for ICTO2018 to be the forerunner in analysis, interpretation and translation of data and knowledge relating to Clinical Trials in Oncology and Hemato-Oncology.

Speakers: talia golan, raanan berger, Robin Foà, Michele Milella, Jens Siveke